Aug 2 (Reuters) - Vaxil Bio Ltd VXL.V :
* VAXIL PROVIDES UPDATE ON RESEARCH ACTIVITIES AND
MANAGEMENT
CHANGES
* VAXIL BIO LTD - EFFECTIVE JULY 31, YUVAL AVNIR, COMPANY'S
CEO
WILL BE REPLACED BY MR. GADI LEVIN, COMPANY'S CURRENT
CHAIRPERSON OF BOARD AND CFO
* VAXIL BIO LTD - EFFECTIVE JULY 31, APPOINTMENT OF ALAN
ROOTENBERG, AS COMPANY'S CFO
* VAXIL BIO LTD - ROOTENBERG WILL BE REPLACING GADI LEVIN,
WHO
TRANSITIONS FROM CFO POSITION TO CEO POSITION
* VAXIL BIO LTD - ACTIVELY EXPLORING STRATEGIC OPTIONS FOR
MAXIMIZING SHAREHOLDER VALUE FROM VAXIL'S ASSETS
Source text for Eikon: ID:nGNXbSvLnN
Further company coverage: VXL.V
((reuters.briefs@thomsonreuters.com;))